This provider's $22.2M in total Medicare payments ranks in the 96th percentile of Clinical Laboratory providers nationally.
Their average markup ratio of 10.42x is significantly above the specialty median of 3.7x.
Medicare payments to this provider grew 6530% from 2014 to 2019.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 1635% in 2015
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $51.53 | $22.27 | 2.31x | $29.26 | $118.7K | 5.3K | 4.6K |
| 2015 | $139.33 | $22.44 | 6.21x | $116.89 | $2.1M | 92.5K | 54.9K |
| 2016 | $4.2K | $118.31 | 35.92x | $4.1K | $2.4M | 12.0K | 7.0K |
| 2017 | $7.5K | $177.36 | 42.28x | $7.3K | $2.7M | 10.8K | 5.6K |
| 2018 | $1.4K | $599.86 | 2.29x | $772.99 | $7.0M | 12.5K | 11.2K |
| 2019 | $934.49 | $572.72 | 1.63x | $361.77 | $7.9M | 10.8K | 10.8K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0483 | Drug test def 22+ classes | 24.2K | $5.6M | $232.94 | 31.84x |
| 81408 | Molecular pathology procedure level 9 | 2.6K | $5.1M | $2.0K | 1.53x |
| 81201 | Gene analysis (adenomatous polyposis coli), full gene sequence | 2.6K | $2.0M | $764.40 | 1.53x |
| 81317 | Gene analysis (postmeiotic segregation increased 2 [S cerevisiae]) full sequence analysis | 2.6K | $1.8M | $676.14 | 1.57x |
| 81298 | Gene analysis (mutS homolog 6 [E coli]) full sequence analysis | 2.6K | $1.6M | $629.01 | 1.53x |
| 81295 | Gene analysis (mutS homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis | 2.6K | $980.8K | $374.07 | 1.53x |
| 81406 | Molecular pathology procedure level 7 | 2.5K | $681.1K | $277.22 | 1.53x |
| 81162 | Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants | 258 | $512.7K | $2.0K | 1.70x |
| 81211 | Gene analysis (breast cancer 1 and 2) full sequence and common duplication or deletion variants | 179 | $420.3K | $2.3K | 1.53x |
| G0482 | Drug test def 15-21 classes | 2.5K | $399.1K | $162.62 | 42.85x |
| G6046 | Dihydromorphinone | 6.5K | $222.2K | $34.22 | 5.70x |
| G6045 | Dihydrocodeinone | 6.5K | $180.0K | $27.49 | 5.70x |
| G6056 | Opiate(s), drug and metabolites, each procedure | 6.5K | $169.1K | $25.90 | 5.69x |
| 82542 | Chemical analysis using chromatography technique | 6.9K | $165.6K | $24.01 | 5.73x |
| G6031 | Benzodiazepines | 6.5K | $160.5K | $24.62 | 5.70x |
| 81292 | Gene analysis (mutL homolog 1, colon cancer, nonpolyposis type 2) full sequence analysis | 234 | $154.9K | $661.89 | 1.53x |
| G6052 | Meprobamate | 6.3K | $146.9K | $23.46 | 5.69x |
| G6053 | Methadone | 6.5K | $140.4K | $21.74 | 5.71x |
| 81321 | Gene analysis (phosphatase and tensin homolog), full sequence analysis | 235 | $138.2K | $588.00 | 2.55x |
| 83992 | PCP drug level | 6.8K | $132.8K | $19.55 | 5.47x |
This provider submits charges 10.42 times higher than what Medicare actually pays.
A markup ratio of 10.42x means for every $100 Medicare pays, this provider initially charges $1042. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in TX for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Clinical Pathology Laboratories, Inc. | Austin, TX | $541.0M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Irving, TX | $453.2M | ⚠️ Flagged |
| Laboratory Corporation Of America | Dallas, TX | $389.6M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Houston, TX | $311.2M | ⚠️ Flagged |
| Laboratory Corporation Of America | Houston, TX | $299.4M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data